Who Paid My Doc
Trisha Kernodle
Nurse Practitioner, Family Anchorage, AK Nurse Practitioner
NPI 1891344297 CMS profile 11212686
910 Compassion Cir, Anchorage, AK 99504
General payments
$60,408
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Trisha Kernodle of Anchorage, AK is reported in the CMS Open Payments database as having received $60,408 across 10 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $60,200 | 4 | |
| 2023 | General | $128 | 5 | |
| 2022 | General | $80 | 1 |
Beside peers
- Trisha Kernodle
- Nurse Practitioner, Family median
- Middle half of Nurse Practitioner, Family
- National median
In program year 2025, general payments to Trisha Kernodle were reported at $0. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.
Show as a table
| Year | Trisha Kernodle | Nurse Practitioner, Family median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $39 | $18–$91 | $163 |
| 2020 | $0 | $32 | $17–$76 | $114 |
| 2021 | $0 | $124 | $35–$379 | $132 |
| 2022 | $80 | $141 | $44–$430 | $149 |
| 2023 | $128 | $154 | $49–$476 | $160 |
| 2024 | $60,200 | $165 | $51–$504 | $164 |
| 2025 | $0 | $168 | $53–$521 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 40 drugsPart D claims
906
Drug cost
$44,663
Branded share of claims
24.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Santyl Collagenase Clostridium Hist. | Brand | 20 | $12,111 | |
| Eliquis Apixaban | Brand | 18 | $7,787 | |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | Brand | 18 | $4,262 | |
| Jardiance Empagliflozin | Brand | 11 | $4,242 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 34 | $1,123 | |
| Oxycodone Hcl | Generic | 59 | $1,059 | |
| Pregabalin | Generic | 35 | $1,031 | |
| Gabapentin | Generic | 56 | $964 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 37 | $823 | |
| Kapspargo Sprinkle Metoprolol Succinate | Brand | 14 | $818 |
The 10 drugs with the highest cost, of 40 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$40,213
Medicare patients
131
Services billed
495
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 53% | |
| Diabetes | 50% | |
| Heart failure | 43% | |
| Depression | 42% | |
| Atrial fibrillation | 41% | |
| Ischemic heart disease | 40% | |
| Chronic kidney disease | 40% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
10 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Family in Alaska
Erica Heagy
Nurse Practitioner, Family · Anchorage, AK
Whitney Carlson
Nurse Practitioner, Family · Soldotna, AK
Randi Hall
Nurse Practitioner, Family · Soldotna, AK
Kristy Blood
Nurse Practitioner, Family · Fairbanks, AK
Casey Blood
Nurse Practitioner, Family · Fairbanks, AK
Marisha Dieters
Nurse Practitioner, Family · Anchorage, AK
Related records
Nurse Practitioner, Family in Alaska
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Family
Everyone recorded under this specialty, nationwide.
Doctors in Alaska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.